What it's actually good for
Vitamin E is a family of eight related compounds — four tocopherols and four tocotrienols — but "vitamin E" on a label almost always means alpha-tocopherol, the form the body retains preferentially. Its core job is straightforward: it's the body's primary fat-soluble antioxidant, protecting cell membranes and circulating LDL particles from oxidative damage. That mechanism isn't in dispute; whether taking more of it once you're already getting enough from food changes any outcome that matters is a different question. This is a case where the biochemistry ran well ahead of the clinical evidence — vitamin E looked like an obvious candidate for preventing heart disease and cancer in the 1990s and was tested in some of the largest supplement trials ever run. Most came back negative, and a couple turned up harm at high doses, which is why this page carries a B despite vitamin E being genuinely essential.
What the research says
Cardiovascular protection (Grade B, leaning negative for supplementation). The HOPE trial randomized 9,541 high-risk patients to 400 IU/day of natural vitamin E or placebo for a median 4.5 years and found no reduction in cardiovascular events; extended follow-up (HOPE-TOO) found supplementation may have increased heart failure risk. The ATBC trial, in Finnish male smokers, likewise found no cardiovascular or lung cancer benefit from alpha-tocopherol. Protecting LDL from oxidation holds up in the lab — it hasn't translated into fewer cardiovascular events across repeated large trials.
Cancer risk at high doses. The SELECT trial randomized 35,533 healthy men to 400 IU/day of vitamin E, selenium, both, or placebo. Vitamin E alone significantly increased prostate cancer risk (HR 1.17 — 76 vs. 65 cases per 1,000 men over 7 years), with no offsetting benefit. A separate meta-analysis of 19 trials and roughly 136,000 participants (Miller et al., 2005) linked doses at or above 400 IU/day to a small increase in all-cause mortality; lower-dose trials showed no such signal. This is why the safety notes here single out sustained high-dose use, not vitamin E itself.
Skin and UV protection (Grade B, mostly small, short-term studies). Oral vitamin E — usually paired with vitamin C — has shown modest reductions in sunburn severity and UV-induced oxidative stress markers in a handful of controlled trials, and topical vitamin C/E combinations measurably reduce erythema and sunburn-cell formation in skin-irradiation studies. Most of this work is small or stacks vitamin E with other antioxidants, making its individual contribution hard to isolate — a plausible, mechanistically grounded benefit, not a proven one.
How much, and which form
The RDA is 15 mg/day (22.4 IU), a target most people reach through nuts, seeds, and vegetable oils without trying. Supplements typically supply 67-400 mg (100-600 IU), well above that baseline. Given the mortality signal at 400+ IU/day, there's little reason to chase high doses: 67-134 mg (100-200 IU) covers any realistic dietary gap without approaching the range where trials started showing harm. Natural d-alpha-tocopherol is retained more efficiently than synthetic dl-alpha-tocopherol; mixed-tocopherol formulas (alpha, beta, gamma, delta) more closely resemble dietary intake than an isolated alpha-tocopherol pill.
Safety & interactions
Vitamin E is safe near RDA levels — the concerns are dose- and duration-dependent. At 400+ IU/day, sustained use is linked to a small increase in all-cause mortality and, per SELECT, a measurable increase in prostate cancer risk in healthy men. It also has real anticoagulant and antiplatelet activity: combined with warfarin or antiplatelet drugs, it raises bleeding risk. There's a theoretical concern that antioxidants blunt the oxidative mechanism some chemotherapy and radiation regimens rely on, so anyone in active cancer treatment should loop in their oncologist first. This is informational, not medical advice — check with a clinician first, particularly on blood thinners or in cancer treatment.
How we picked the brand
A vitamin E product earns a spot when it uses a low-to-moderate dose well under the 400 IU range linked to harm in trials, states the tocopherol form clearly, and passes independent third-party testing.